EN

KO

GeneMatrix

Products
- Molecular Diagnostics
  
  Sexually Transmitted Infections
  
  NeoPlex™ STI-14 Detection
  
  NeoPlex™ STI-7 Detection
  
  NeoPlex™ STI-7 PLUS Detection
  
  Human Papillomavirus Infections
  
  NeoPlex™ HPV29 Detection
  
  NeoPlex™ HPV HR
  
  Respiratory Infections
  
  NeoPlex™ RV-Panel A Detection
  
  NeoPlex™ RV-Panel B Detection
  
  NeoPlex™ RB-8 Detection
  
  NeoPlex™ FluCOVID Detection
  
  NeoPlex™ COVID-19 FAST
  
  NeoPlex™ COVID-19 Detection
  
  Tuberculosis
  
  NeoPlex™ TB/NTM-5 Detection
  
  Gastrointestinal Infections
  
  NeoPlex™ GI-Virus 6 Detection
Experience NeoPlex™ for optimized user efficiency through multiplexing.

Maximize your diagnostic efficiency with our multiplex molecular diagnostic assays.
R&D
Single-tube Multiplex PCR

Explore GeneMatrix’s proprietary multiplex technology that enables simultaneous identification in a single tube.

Research for vaccine development

Explore our R&D capabilities to develop next-generation vaccines.
Support
- Resources
- Videos
- Inquiry
Product and academic inquiries

Connect with a product representative. We quickly respond to your inquiries.
About Us
GeneMatrix 20 years

Look at the GeneMatrix's milestones in pioneering innovation in the field of molecular diagnostics.
News
- News
- Conferences & Exhibitions
Latest news

Explore GeneMatrix's latest news and updates.

KO

News

Genematrix has turned a profit - operating profit reached 2.2 billion Won last year

Feb 15, 2021

Herald Corporation.

https://news.heraldcorp.com/view.php?ud=20210215000875